Adrenolipoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Category) |
||
Line 16: | Line 16: | ||
[[Category:Endocrine system]] | [[Category:Endocrine system]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Surgery]] |
Latest revision as of 02:39, 24 October 2017
Adrenolipoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Adrenolipoma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Adrenolipoma epidemiology and demographics |
Risk calculators and risk factors for Adrenolipoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
The incidence of adrenolipoma is approximately 0.8-4 per 100,000 individuals worldwide. Adrenolipoma affects men and women equally.[1]
Epidemiology and Demographics
Incidence
The incidence of adrenolipoma is approximately 0.8-4 per 100,000 individuals worldwide.
Gender
Adrenolipoma affects men and women equally.[1]